prrsv
member
arterivirida
famili
along
equin
arter
viru
eav
lactat
dehydrogenas
elev
viru
ldv
mice
simian
hemorrhag
fever
viru
shfv
prrsv
genom
positivesens
singlestrand
rna
approxim
kb
encod
open
read
frame
orf
orf
includ
firth
et
al
johnson
et
al
b
code
two
larg
polyprotein
cleav
nonstructur
protein
fang
snijder
seven
structur
protein
encod
glycoprotein
gp
small
envelop
e
membran
nucleocapsid
n
protein
protein
dea
et
al
meulenberg
et
al
form
dimer
form
heterotrim
shown
facilit
viral
entri
host
cell
wissink
et
al
prrsv
group
genotyp
european
type
north
american
type
ii
signific
genet
differ
two
genotyp
addit
signific
heterogen
among
strain
within
genotyp
give
rise
signific
number
antigen
distinct
virus
although
clear
antigen
classif
scheme
develop
thu
protect
heterolog
virus
vaccin
highli
sought
prrsv
infect
persist
numer
research
studi
shown
viru
isol
lymphoid
tissu
month
initi
infect
allend
et
al
howev
implement
herd
closur
farm
stabil
protocol
use
exposur
wildtyp
prrsv
shown
viru
elimin
individu
anim
herd
torremorel
et
al
therefor
pig
immun
system
capabl
mount
respons
eventu
resolv
infect
elimin
viru
anim
entir
howev
clearanc
diseas
resolut
take
signific
amount
time
herd
closur
protocol
indic
day
ultim
tell
us
pig
eventu
see
prrsv
context
necessari
develop
protect
immun
elimin
viru
bodi
context
like
involv
proper
innat
immun
activ
adequ
direct
develop
protect
adapt
immun
portion
viru
immun
system
must
target
eventu
recogn
immun
cell
necessari
mediat
clearanc
induc
although
take
long
time
clearanc
natur
infect
subsequ
convalesc
immun
use
correl
specif
immun
paramet
cell
antibodi
particular
prrsv
epitop
involv
protect
dissect
immun
develop
postexposur
question
remain
take
long
get
protect
immun
respons
clear
prrsv
infect
follow
review
focus
type
prrsv
structur
base
differ
arm
immun
respons
antibodi
cellmedi
innat
intent
outlin
factor
associ
protect
lack
thereof
well
accept
neutral
antibodi
key
compon
steril
immun
vaccinebas
immun
rapid
induct
neutral
antibodi
ultim
goal
would
provid
protect
infect
induct
antibodi
secret
b
cell
requir
cell
help
cell
requir
kill
viral
infect
cell
howev
know
littl
mechanist
cellmedi
immun
prrsv
final
section
relat
innat
immun
present
last
aim
tie
togeth
find
describ
adapt
immun
prrsv
mention
know
pig
eventu
see
prrsv
clear
infect
thu
identifi
epitop
immun
cell
necessari
clearanc
pair
antigen
context
proper
innat
immun
activ
necessari
find
solut
enhanc
prrsv
immun
develop
strategi
significantli
decreas
time
take
develop
protect
immun
earli
prrsv
exposur
vigor
antiprrsv
antibodi
respons
measur
initi
detect
day
postinfect
pi
howev
evid
earli
antibodi
respons
play
role
protect
prrsv
infect
labarqu
et
al
yoon
et
al
antibodi
appear
earli
pi
period
neutral
prrsv
vitro
yoon
et
al
use
passiv
protect
experi
earli
pi
antibodi
ie
serum
antibodi
collect
day
pi
mediat
passiv
protect
challeng
virul
antibodymatch
prrsv
rather
seemingli
enhanc
virul
infect
lopez
et
al
serum
antibodi
prrsvneutral
activ
appear
later
pi
time
specif
period
equal
higher
day
pi
meier
et
al
meier
et
al
yoon
et
al
kinet
antibodi
develop
especi
antibodi
direct
major
structur
protein
n
prrsv
studi
experiment
challeng
pig
loemba
et
al
nelson
et
al
prrsvspecif
igm
detect
day
pi
titer
peak
day
pi
decreas
undetect
level
around
day
pi
antiprrsv
igg
peak
day
day
pi
level
remain
elev
persist
phase
infect
earliest
antibodi
detect
direct
kda
n
protein
follow
kda
protein
kda
envelop
glycoprotein
loemba
et
al
interestingli
contain
cluster
nonneutr
epitop
suggest
immunodomin
role
major
nonstructur
ns
protein
de
lima
et
al
oleksiewicz
et
al
commonli
use
prrsv
serolog
test
idexx
lab
portland
main
us
detect
antibodi
mainli
n
protein
antibodi
appear
around
first
week
pi
persist
sever
month
correl
protect
lopez
et
al
lopez
osorio
although
n
protein
commonli
use
diagnost
antigen
shown
sever
ns
protein
induc
antibodi
base
kinet
persist
rival
n
diagnost
antigen
mayb
better
target
brown
et
al
johnson
et
al
mulupuri
et
al
antibodi
enhanc
infect
import
prrsv
primarili
macrophagetrop
viru
given
known
macrophagetrop
virus
initi
plausibl
propos
role
antibodydepend
enhanc
ade
infect
prrsv
occurr
ade
vitro
vivo
report
gu
et
al
yoon
et
al
yoon
et
al
report
contribut
establish
notion
antiprrsv
antibodi
particularli
earli
antibodi
neutral
viru
preced
neutral
respons
time
appear
robust
could
enhanc
diseas
caus
prrsv
deleteri
host
appear
possibl
demonstr
occurr
ade
cultur
swine
macrophag
prrsv
vitro
real
role
ade
vivo
exist
remain
unclear
like
hold
littl
signific
overal
pathogenesi
prr
actual
occurr
ade
prrsvinfect
macrophag
best
controversi
differ
laboratori
report
differ
success
detect
ade
delputt
et
al
yoon
et
al
contrast
experiment
result
differ
lab
ascrib
viru
strain
swine
macrophag
differ
delputt
et
al
content
per
se
limit
significantli
put
overal
pathogen
import
ade
regard
vivo
proof
occurr
ade
two
experi
cite
one
case
report
passiv
transfer
subneutr
titer
prrsv
follow
prrsv
challeng
result
enhanc
viremia
log
group
receiv
viru
without
induc
clinic
exacerb
yoon
et
al
anoth
report
describ
passiv
transfer
saltconcentr
nonneutr
igg
igg
collect
day
pi
follow
prrsv
challeng
led
increas
rectal
temperatur
caus
increas
interstiti
pneumonia
lopez
et
al
howev
author
could
rule
possibl
increas
patholog
observ
caus
presenc
proinflammatori
cytokin
cosalt
igg
fraction
collect
day
pi
donor
sera
rather
nonneutr
igg
known
signific
amount
proinflammatori
mediat
like
contain
serum
prrsvinfect
anim
first
week
post
infect
van
reeth
et
al
van
reeth
nauwynck
summari
would
appear
degre
pathogen
ade
contribut
prrsv
infect
could
distinguish
overal
patholog
caus
introduct
serum
cytokin
prrsv
infect
pig
would
coprecipit
igg
overal
contribut
ade
prr
pathogenesi
unlik
critic
discuss
recent
review
murtaugh
genzow
earli
observ
virusspecif
antibodi
sera
prrsv
convalesc
pig
display
abil
neutral
infecti
prrsv
absenc
complement
attract
interest
mani
research
nelson
et
al
yoon
et
al
howev
time
initi
systemat
studi
prrsv
pathogenesi
carri
earli
data
show
simultan
presenc
prrsv
prrsvspecif
antibodi
serum
infect
pig
interpret
indic
neutral
antibodi
nab
play
role
protect
albina
collin
loemba
et
al
molitor
molitor
et
al
snijder
meulenberg
time
idea
prrsv
antibodi
produc
earli
follow
infect
present
absenc
neutral
antibodi
could
exacerb
prrsv
replic
macrophag
vitro
vivo
yoon
et
al
led
gener
conclus
antiprrsv
antibodi
play
nonprotect
deleteri
role
diseas
review
snijder
meulenberg
due
slow
irregular
appear
prrsv
neutral
antibodi
follow
prrsv
infect
much
credit
given
role
neutral
antibodi
prrsv
protect
andor
clearanc
overal
literatur
relat
role
nab
prrsv
infect
anyth
confus
exampl
report
describ
persist
infecti
prrsv
lymphoid
tissu
eg
tonsil
week
pi
anim
high
titer
circul
homolog
prrsvnab
interpret
consist
idea
prrsv
nab
incap
clear
viru
will
et
al
howev
data
indic
nab
prevent
appear
viremia
likewis
immun
prrsv
protein
basto
et
al
dea
confer
degre
protect
infect
protect
correl
appear
serum
nab
serum
transfer
experi
conduct
osorio
et
al
provid
unequivoc
evid
prrsv
nab
alon
fulli
prevent
transplacent
prrsv
infect
piglet
prevent
prrsv
infect
pregnant
femal
transfer
nab
provid
steril
immun
dam
piglet
utero
subsequ
challeng
sinc
prrsv
could
detect
lymphoid
organ
viru
isol
rtpcr
swine
bioassay
either
dam
offspr
along
line
later
observ
passiv
transfer
nab
piglet
directli
time
prior
challeng
protect
prrsv
infect
though
protect
depend
amount
antibodi
transfer
lopez
et
al
passiv
transfer
experi
piglet
also
indic
signific
differ
result
obtain
gestat
sow
passiv
transfer
nab
piglet
concentr
would
attain
endpoint
around
provid
steril
immun
piglet
observ
transmiss
prrsv
penmat
piglet
passiv
receiv
nab
challeng
although
viremia
detect
likewis
addit
experi
indic
higher
concentr
antibodi
transfer
ie
attain
endpoint
titer
capabl
provid
steril
immun
piglet
report
passiv
transfer
nab
gestat
sow
requir
endpoint
titer
paradox
result
like
consequ
differ
suscept
overal
capac
prrsv
replic
adult
sow
versu
piglet
piglet
target
cell
macrophag
much
permiss
prrsv
replic
consequ
ensu
viral
load
tissu
higher
young
pig
sow
data
suggest
vaccin
may
need
elicit
higher
titer
nab
younger
pig
effect
target
popul
howev
point
clearli
demonstr
warrant
investig
major
confound
factor
imped
accur
evalu
role
nab
prrsv
protect
fact
mani
author
attempt
interpret
valu
nab
use
postexposur
correl
develop
nab
resolut
infect
oppos
prophylact
capac
nab
prevent
prrsv
infect
analyz
nab
respons
upon
natur
wildtyp
prrsv
infect
demonstr
nab
produc
rapidli
enough
limit
establish
chronic
infect
nelson
et
al
addit
kinet
appear
antibodi
major
candid
target
nab
coincid
clearanc
viremia
mulupuri
et
al
observ
prrsv
persist
tissu
even
appear
nab
allend
et
al
collect
observ
led
conclus
nab
contribut
control
prrsv
follow
infect
abil
prophylact
antiprrsv
nab
provid
protect
subsequ
challengeexposur
complet
separ
experiment
question
correl
appear
nab
infect
viral
clearanc
former
question
whether
vaccineinduc
nab
separ
arm
immun
system
provid
protect
diseas
later
question
mechan
resolut
follow
natur
infect
delin
two
concept
import
draw
conclus
role
differ
immun
paramet
provid
protect
prrsv
worth
note
sourc
nab
prophylact
passiv
transfer
studi
deriv
experiment
challeng
pig
indic
cours
infect
pig
produc
antibodi
prevent
infect
overal
experi
prophylact
administr
nab
establish
specif
titer
nab
requir
prevent
subsequ
infect
respect
immun
regimen
give
rise
protect
level
nab
blood
subsequ
serum
nab
titer
serv
correl
protect
plotkin
gilbert
recent
public
analyz
respons
larg
number
anim
differ
prrsv
vaccin
regimen
li
et
al
indic
nab
possibl
correl
vaccineinduc
protect
prrsv
howev
kept
mind
protect
nab
titer
blood
ie
hard
obtain
one
applic
current
avail
prrsv
vaccin
han
et
al
roca
et
al
tru
et
al
zuckermann
et
al
nab
specif
vaccin
strain
homolog
signific
titer
crossneutr
antibodi
rare
vu
et
al
zhou
et
al
anamnest
induct
nab
observ
heterolog
challeng
previous
sensit
vaccin
previous
infect
anim
indic
good
prognosi
broad
heterolog
protect
anamnest
nab
respons
seem
occur
certain
period
time
elaps
primari
sensit
subsequ
secondari
heterolog
challeng
necessari
length
time
appear
month
challeng
one
month
less
anamnest
nab
respons
detect
osorio
et
al
scortti
et
al
zuckermann
et
al
overal
serum
nab
respons
prrsv
repeatedli
studi
character
differ
group
although
littl
known
locat
promin
neutral
epitop
prr
virion
initi
investig
direct
locat
neutral
epitop
prr
virion
focus
envelop
glycoprotein
protein
like
interact
host
cell
protein
mediat
viral
penetr
cell
structur
protein
prrsv
envelop
small
envelop
e
protein
gene
product
alreadi
rule
induc
neutral
antibodi
robinson
et
al
wu
et
al
earli
paper
report
monoclon
antibodi
specif
van
nieuwstadt
et
al
possess
prrsvneutral
capac
led
signific
investig
two
glycoprotein
main
target
serum
nab
emphasi
place
numer
initi
studi
propos
major
neutral
epitop
locat
dea
weiland
et
al
yang
et
al
besid
neutral
epitop
least
anoth
neutral
epitop
recogn
monoclon
antibodi
envelop
van
nieuwstadt
et
al
yang
et
al
anoth
envelop
protein
yang
et
al
recent
singl
amino
acid
protein
shown
necessari
polyclon
swine
antibodi
mediat
broadli
neutral
activ
tribl
et
al
initi
revers
vaccinolog
studi
addit
report
propos
main
neutral
epitop
target
nab
locat
ectodomain
ostrowski
et
al
plagemann
et
al
minimum
antigen
area
epitop
compris
amino
acid
core
main
neutral
epitop
ostrowski
et
al
data
establish
notion
main
neutral
epitop
locat
ectodomain
notion
would
consist
arterivirida
neutral
epitop
eav
ldv
ectodomain
gl
respect
neutral
epitop
assum
linear
epitop
howev
data
show
neutral
epitop
conform
rather
linear
fan
et
al
li
murtaugh
pirzadeh
dea
conform
natur
neutral
epitop
first
describ
pirzadeh
dea
show
immun
prrsv
dna
vaccin
encod
elicit
product
serum
nab
immun
recombin
protein
produc
bacteria
dna
construct
fail
induc
product
nab
recent
two
independ
report
conclud
ectodomain
contain
linear
neutral
epitop
prrsv
type
vanhe
et
al
prrsv
type
li
murtaugh
strain
summari
origin
observ
dna
immun
singl
gene
alon
evok
antibodi
effici
neutral
prrsv
infect
still
hold
true
confirm
multipl
subsequ
independ
report
use
possibl
subunit
candid
make
experiment
vaccin
base
alon
express
dimer
jiang
et
al
kim
et
al
pirzadeh
dea
vanhe
et
al
xu
et
al
zheng
et
al
zhou
et
al
case
alon
express
multipl
differ
vaccin
platform
elicit
prrsvneutral
antibodi
consist
evid
sequenti
epitop
ectodomain
exist
assum
neutral
epitop
exist
prrsv
conform
fan
et
al
protein
form
dimer
contribut
conform
natur
neutral
epitop
recent
two
import
piec
inform
signific
impact
view
role
specif
prrsv
glycoprotein
target
antibodymedi
viru
neutral
first
one
major
discoveri
unequivoc
recognit
per
se
determin
host
cell
tropism
prrsv
thu
suggest
interact
main
cellular
receptor
prrsv
instead
cluster
minor
prrsv
glycoprotein
interact
host
cell
initi
infect
tian
et
al
second
notion
interact
form
multiprotein
complex
present
scarc
number
viru
envelop
least
would
protein
interact
main
membran
endosom
receptor
prrsv
penetr
see
fig
da
et
al
inform
stimul
signific
interest
minor
glycoprotein
role
antibodi
target
neutral
prrsv
peptid
scan
technolog
led
identif
peptid
defin
actual
linear
neutral
epitop
three
minor
glycoprotein
interestingli
none
vanhe
et
al
glycoprotein
interact
main
cellular
receptor
prrsv
contain
conserv
residu
contact
interact
host
cell
entri
epitop
would
candid
vaccin
antigen
induct
broadli
neutral
antibodi
may
signific
crossprotect
work
area
warrant
determin
actual
case
persist
prrsv
infect
individu
anim
one
biggest
obstacl
control
diseas
field
possibl
mechan
could
explain
persist
given
great
pathogen
signific
sinc
initi
report
nglycan
moieti
typeii
prrsv
import
viru
escap
effect
nab
ansari
et
al
faaberg
et
al
glycan
shield
postul
primari
mechan
explain
evas
neutral
antibodi
respons
ensur
vivo
persist
viru
previous
report
simian
human
immunodefici
viru
influenza
viru
hepat
c
viru
ebola
viru
francica
et
al
liu
et
al
reitter
et
al
wang
et
al
wei
et
al
furthermor
experi
would
confirm
previou
find
observ
suggest
also
nglycan
typeii
prrsv
would
also
import
protect
viru
antibodi
neutral
vu
et
al
recent
report
involv
deglycosyl
experi
prrsv
type
ii
strain
provid
support
conclus
glycosyl
downstream
put
neutral
epitop
render
prrsv
resist
neutral
wei
et
al
b
though
effect
could
confirm
wei
et
al
regardless
whether
glycosyl
contribut
overal
glycan
shield
neutral
epitop
overal
bodi
hypoglycosyl
experi
vu
et
al
firmli
confirm
import
role
induct
neutral
antibodi
concept
alreadi
suggest
previou
investig
canceltirado
et
al
jiang
et
al
kim
yoon
plana
duran
et
al
recent
work
vanhe
et
al
clearli
demonstr
contain
import
linear
neutral
epitop
also
import
mention
use
hypoglycosyl
version
prrsv
gener
revers
genet
intent
enhanc
abil
live
viru
vaccin
elicit
neutral
antibodi
ansari
et
al
sever
limit
short
life
span
hypoglycoysl
phenotyp
vivo
viru
replic
vivo
quickli
lead
revers
wildtyp
glycan
shield
version
gp
osorio
pattnaik
univers
nebraska
unpublish
data
howev
possibl
signific
induct
serum
nab
immun
recombin
inactiv
hypoglycosyl
form
administ
adjuv
nonrepl
immunogen
deserv
consider
addit
studi
recent
publish
passiv
transfer
experi
demonstr
nab
bona
fide
paramet
prrsv
protect
immun
import
mediat
protect
prrsv
mani
differ
prrsv
vaccin
candid
evalu
protect
homologousheterolog
challeng
plu
abil
induc
crossneutr
antibodi
passiv
protect
prophylact
administr
nab
demonstr
valu
prevent
infect
protect
consist
provid
homolog
condit
ie
condit
close
ident
nab
specif
challeng
strain
alreadi
discuss
initi
studi
aim
identifi
locat
neutral
epitop
prrsv
posit
primari
immunogen
target
crossprotect
known
form
heterodim
nonglycosyl
protein
virion
envelop
enhanc
immunogen
product
nab
explain
worldwid
use
alon
combin
immunogen
differ
platform
construct
test
subunit
vaccin
candid
prrsv
attempt
includ
amongst
other
viral
vector
dna
vaccin
well
genet
adjuv
immunomodul
regardless
platform
formul
becom
obviou
use
subunit
alon
although
immunogen
somewhat
protect
suffici
provid
complet
protect
vaccin
contain
subunit
provid
limit
protect
homolog
challeng
provid
less
protect
attain
modifi
live
viru
vaccin
thu
alon
even
formul
protein
unlik
serv
vaccin
immunogen
homolog
heterolog
protect
signific
advanc
delin
role
immun
prrsv
glycoprotein
play
protect
deriv
studi
interact
amongst
four
prrsv
envelop
glycoprotein
da
et
al
look
either
interact
prrsv
surfac
glycoprotein
main
cellular
receptor
abl
show
strong
interact
lesser
extent
interact
minor
glycoprotein
protein
part
found
interact
gp
result
format
multiprotein
complex
see
fig
remark
result
show
protein
specif
exclus
interact
molecul
da
et
al
recent
report
wei
et
al
confirm
interact
unabl
confirm
particip
interact
wei
et
al
overal
da
et
al
conclud
critic
mediat
interglycoprotein
interact
along
serv
protein
respons
mediat
interact
viru
entri
host
cell
group
report
similar
find
work
european
martinezlobo
et
al
us
strain
hess
et
al
studi
china
use
chimer
virus
obtain
revers
genet
seem
confirm
da
et
al
origin
content
suggest
prrsv
cluster
respons
interact
fig
shown
structur
extracellular
region
repeat
unit
srcr
domain
project
plasma
membran
host
cell
although
multiprotein
complex
like
one
propos
da
et
al
detect
experi
transfect
cell
molar
ratio
protein
complex
still
unknown
although
major
glycoprotein
envelop
may
distribut
uniformli
throughout
viral
envelop
one
hypothes
complex
possibl
two
three
per
particl
shown
fig
may
respons
bind
cryoelectron
microscop
studi
publish
dokland
et
al
spilman
et
al
suggest
two
three
larg
protein
complex
seen
viral
envelop
thu
provid
addit
support
hypothesi
model
view
possibl
may
inde
respons
stimul
antibodi
would
block
interact
main
host
cell
receptor
resurfac
interest
two
protein
rather
neglect
base
primari
interest
gener
believ
major
prrsv
immunogen
induct
nab
although
origin
find
induc
neutral
antibodi
still
hold
evid
collect
laboratori
univers
nebraska
ansari
et
al
would
indic
rather
evok
broadli
reactiv
panneutr
antibodi
would
appear
evok
primarili
strainspecif
antibodi
mention
recent
public
would
assign
protein
rather
abil
induc
crossneutr
antibodi
tribl
et
al
evid
strain
specif
charact
induc
alon
come
experi
use
revers
genet
gener
strain
prrsv
deglycosyl
clone
glycan
shield
abil
prrsv
show
deglycosyl
form
result
signific
prrsvnab
wherea
glycosyl
form
stimul
signific
product
nab
ansari
et
al
howev
titer
increas
homolog
viru
significantli
increas
heterolog
strain
prrsv
vu
et
al
thu
plausibl
conclud
antibodi
target
receptorbind
region
would
prevent
entri
viru
host
cell
serv
neutral
infect
likewis
mutat
region
andor
directli
interact
cellular
receptor
would
render
viru
incap
infect
mutat
would
select
infect
consist
view
hypothesi
could
made
antibodi
direct
glycoprotein
epitop
conserv
across
differ
prrsv
strain
necessari
viral
attach
entri
would
abl
neutral
multipl
prrsv
strain
word
would
crossneutr
one
major
piec
evid
support
conclus
certain
prrsv
epitop
capabl
induc
product
crossneutr
antibodi
come
observ
pig
vaccin
mlv
vaccin
protect
secondari
heterolog
challeng
osorio
et
al
specif
fraction
pig
initi
respond
mlv
vaccin
product
serum
nab
vaccin
antigen
robust
strainspecif
increas
serum
nab
titer
follow
heterolog
challeng
correl
protect
secondari
challeng
osorio
et
al
scortti
et
al
phenomenon
interpret
evid
protect
crossneutr
occur
prrsv
alway
occur
martinezlobo
et
al
osorio
et
al
data
suggest
mlv
prime
immun
system
secondari
challeng
requir
nab
detect
system
mechan
mlv
prime
crossprotect
unclear
could
memori
b
cell
memori
cell
combin
howev
induct
anamnest
respons
suggest
secondari
challeng
viru
replic
respons
though
may
result
detect
viremia
research
area
warrant
understand
epitop
nab
direct
well
immun
memori
compart
prime
mlv
understand
mechan
lead
understand
prime
prrsv
collect
data
suggest
nab
present
time
challeng
signific
enough
titer
provid
steril
immun
challeng
antiprrsv
antibodi
deriv
activ
immun
provid
protect
deliv
prophylact
passiv
transfer
specif
epitop
nab
recogn
complet
defin
recent
work
suggest
import
role
antibodi
direct
minor
glycoprotein
complex
gener
viral
surfac
prior
exposur
either
natur
use
mlv
vaccin
prime
pig
immun
system
robust
secondari
antibodi
respons
indic
protect
unclear
take
long
peripher
nab
appear
follow
challengemlv
vaccin
role
nab
clearanc
follow
infect
shield
epitop
may
mechan
prrsv
evad
host
immun
system
howev
pig
eventu
develop
detect
serum
nab
prime
anamnest
respons
provid
protect
heterolog
infect
cell
play
critic
role
mani
aspect
antiprrsv
immun
due
central
role
develop
regul
antigenspecif
immun
respons
includ
educ
activ
b
cell
determin
cytokin
milieu
environ
antigen
present
cytotox
effector
function
destroy
infect
cell
regul
immun
respons
control
inflamm
monitor
autoimmun
reaction
expans
toolkit
function
biochem
assay
use
character
cell
respons
mice
larg
unavail
swine
due
pauciti
reagent
inabl
clone
antigenspecif
cell
inabl
expand
immort
antigenspecif
cell
howev
known
review
cell
subpopul
swine
character
primarili
cluster
differenti
cd
marker
phenotyp
secret
interferongamma
notabl
swine
signific
popul
matur
extrathym
doubleposit
cell
repres
memori
cell
zuckermann
husmann
thu
like
play
role
memori
respons
cell
capabl
produc
local
site
inflamm
suggest
play
role
mediat
protect
immun
zuckermann
work
within
limit
known
substanti
transient
decreas
cell
occur
blood
day
infect
return
normal
level
day
infect
nielsen
botner
shimizu
et
al
increas
cell
frequent
observ
usual
week
infect
albina
et
al
dwivedi
et
al
kawashima
et
al
shimizu
et
al
cell
also
increas
infect
lung
wherea
cell
fewer
rare
samsom
et
al
tingstedt
nielsen
increas
doubleposit
cell
also
observ
lymphoid
tissu
gomezlaguna
et
al
cell
respons
prrsv
also
includ
cell
littl
known
signific
olin
et
al
piglet
infect
utero
reduc
number
circul
cell
observ
birth
one
week
age
day
number
return
normal
wherea
cell
substanti
increas
feng
et
al
nielsen
et
al
utero
infect
also
associ
mrna
express
feng
et
al
antigenspecif
lymphocyt
prolifer
first
detect
four
week
postinfect
pi
peak
week
pi
declin
week
pi
experi
util
block
antibodi
specif
porcin
leukocyt
antigen
demonstr
main
effector
cell
type
prolifer
tcell
vivo
cell
respons
prrsv
shown
detect
specif
dosedepend
delayedtyp
hypersensit
dth
reaction
infect
pig
intraderm
administr
uvinactiv
viru
evolut
prrsvspecif
cell
respons
time
follow
infect
primarili
assess
elispot
assay
depend
assay
perform
give
measur
number
nk
cell
helper
cell
andor
cytotox
cell
produc
peripher
prrsvspecif
cell
observ
week
infect
extens
variat
time
among
anim
xiao
et
al
signific
differ
observ
prrsvspecif
cell
lymphoid
tissu
examin
virem
postvirem
infect
correl
prrsvspecif
cell
frequenc
viral
load
lymphoid
tissu
xiao
et
al
nearli
case
frequenc
specif
secret
cell
low
regardless
age
kling
et
al
secret
also
use
indic
polar
helper
cell
respons
prrsv
infect
identifi
candid
treatment
potenti
antivir
immun
meier
et
al
xiao
et
al
howev
signific
secret
indic
helper
cell
polar
uncertain
swine
sinc
phenotyp
secret
cell
usual
known
multipl
lymphocyt
popul
capabl
secret
report
cell
phenotyp
pig
dawson
et
al
ebner
et
al
thorough
character
paradigm
swine
relev
prrsv
immun
establish
day
vaccin
low
virusspecif
secret
cell
respons
observ
consist
ctl
respons
ferrari
et
al
immun
activ
influenc
isol
rout
administr
ferrari
et
al
howev
cytotox
effector
function
cell
strongli
link
control
primari
prrsv
infect
temporari
deplet
cell
time
infect
lead
increas
infect
suggest
cytotox
cell
function
role
control
acut
infect
lohs
et
al
similarli
ctl
activ
detect
prrsvinfect
macrophag
viremia
clear
coster
et
al
memori
ctl
prolifer
observ
day
infect
ctl
activ
detect
day
infect
coster
et
al
data
suggest
ctl
may
involv
clearanc
prrsvinfect
cell
tissu
howev
effect
prrsv
infect
cell
frequenc
lymphoid
tissu
establish
extens
survey
prrsvspecif
cell
frequenc
lung
lymphoid
tissu
acut
prolong
infect
show
signific
chang
xiao
et
al
wherea
anoth
studi
prolong
presenc
prrsv
lymphoid
tissu
associ
elev
level
highli
posit
cell
lamontagn
et
al
prrsv
infect
report
increas
frequenc
put
regulatori
cell
treg
produc
silvacampa
et
al
type
prrsv
strain
induc
product
infect
dendrit
cell
cocultur
lymphocyt
induc
treg
cell
product
silvacampa
et
al
contrast
type
prrsv
infect
dendrit
cell
increas
treg
induc
product
silvacampa
et
al
recent
work
indic
monocytederiv
dendrit
cell
infect
either
type
type
prrsv
increas
frequenc
prolifer
regulatori
cell
vitro
cocultur
system
rodriguezgomez
et
al
prrsv
induct
treg
suppress
activ
occur
vitro
vivo
wongyanin
et
al
induc
treg
suppress
mitogen
prolifer
peripher
blood
mononuclear
cell
earli
induct
treg
prrsv
infect
dendrit
cell
would
provid
mechan
facilit
establish
viral
infect
inconsist
observ
might
due
variat
subpopul
lymphocyt
express
transcript
factor
immunosuppress
cytokin
express
differ
cecer
et
al
altern
secret
treg
induct
explan
difficulti
resolv
prrsv
infect
lymphoid
apoptosi
use
histolog
viral
antigen
express
gomezlaguna
et
al
show
mainli
lymphocyt
b
cell
cell
area
lymphoid
tissu
apoptot
pig
infect
type
prrsv
et
al
loss
cell
may
result
low
number
prrsvspecif
cell
detect
infect
howev
direct
link
lymphoid
apoptosi
lack
prrsvspecif
cell
clearli
establish
addit
mark
lymphadenopathi
associ
prrsv
infect
explain
clearli
addit
research
need
resolv
question
role
memori
cell
antiprrsv
immun
studi
extens
report
recal
respons
mainli
depend
cell
slaii
present
week
infect
remain
month
lopez
fuert
et
al
major
studi
evalu
cell
respons
prrsv
investig
respons
acut
infect
rather
follow
clearanc
viremia
infect
assum
primarili
effector
cell
detect
oppos
memori
cell
distinct
effector
versu
memori
cell
difficult
swine
due
lack
phenotyp
marker
function
character
individu
cell
popul
clearli
evalu
vaccin
immunogen
efficaci
warrant
measur
prrsvspecif
memori
cell
howev
memori
cell
clearli
character
pig
prrsv
antigen
target
cellmedi
immun
investig
use
variou
immun
assay
commonli
use
evalu
antigenspecif
respons
incub
pbmc
prrsvinfect
noninfect
pig
presenc
envelop
glycoprotein
gp
matrix
protein
induc
prolif
respons
bautista
et
al
analysi
identifi
immunodomin
epitop
includ
conserv
amino
acid
region
residu
use
secretingcel
elispot
assay
burgaraestrella
et
al
vashisht
et
al
conserv
cell
epitop
identifi
n
type
prrsv
epitop
correspond
epitop
report
type
prrsv
diaz
et
al
elispot
also
use
identifi
four
conserv
cell
peptid
matrix
membran
protein
chines
highli
pathogen
prrsv
strain
wang
et
al
nonstructur
protein
repertoir
conserv
epitop
identifi
type
prrsv
stimul
antigenspecif
prolifer
secret
burgaraestrella
et
al
parida
et
al
peptid
stimul
secret
also
observ
inhibit
respons
pbmc
stimul
mitogen
note
low
respond
pig
tend
homozyg
sla
haplotyp
signific
observ
pursu
burgaraestrella
et
al
outbr
pig
model
develop
evalu
antigenspecif
cell
respons
prrsv
swine
immun
plasmid
construct
express
porcin
granulocytemacrophag
colonystimul
factor
gmcsf
prrsv
n
gener
sourc
potenti
antigenspecif
cell
wang
et
al
dendrit
cell
deriv
pig
load
recombin
protein
use
mhcmatch
autolog
antigenpres
cell
apc
stimul
pbmc
pig
cell
prolifer
synthesi
induc
immun
pig
respons
n
stimulatori
contrast
serum
antibodi
produc
n
jeong
et
al
approach
use
cell
mhcmatch
autolog
apc
identifi
cell
epitop
like
use
futur
studi
inabl
pig
achiev
rapid
steril
immun
prrsv
may
due
larg
part
inadequ
cell
respons
sinc
cell
play
central
role
direct
effector
respons
infect
overal
immun
activ
modul
appropri
cell
b
cell
respons
regul
respons
intens
durat
mainten
immun
memori
essenti
role
cell
resist
viral
infect
diseas
known
primarili
studi
defin
cell
popul
specif
expand
maintain
cell
cultur
genet
delet
defin
cell
popul
anim
examin
cellular
anim
respons
infect
experiment
system
result
detail
dissect
cellular
properti
molecular
mechan
explain
key
featur
rapidli
steril
immun
varieti
viral
infect
anim
featur
oper
way
pig
infect
prrsv
howev
abil
perform
detail
investig
identifi
molecular
mechan
gone
awri
possibl
thu
essenti
develop
cell
biolog
toolkit
swine
investig
antigenspecif
expans
growth
normal
porcin
helper
cytotox
cell
well
immort
antigenspecif
helper
cytotox
cell
time
essenti
develop
mhc
class
class
ii
antigenpresent
cultur
system
function
assess
helper
cytotox
cell
function
vitro
condit
repres
prr
diseas
pregnant
sow
grow
pig
enlarg
immun
reagent
toolkit
essenti
phenotyp
character
cell
subpopul
basi
describ
cell
subset
new
better
method
must
found
character
respons
activ
cell
term
biolog
activ
secret
molecul
alter
express
surfac
molecul
chang
abil
respond
local
environ
genet
tool
need
introduc
delet
target
gene
function
test
potenti
causal
relationship
place
associ
studi
often
time
difficult
reproduc
key
invest
basic
porcin
cellular
immunolog
essenti
unravel
mechan
protect
prr
benefit
invest
accru
better
control
prevent
prr
also
directli
applic
viral
diseas
swine
numer
everexpand
effect
innat
antivir
immun
respons
product
type
interferon
ifn
virusinfect
cell
induc
antivir
state
express
numer
interferonstimul
gene
baum
garciasastr
although
cell
type
abl
produc
type
ifn
respons
viral
infect
cytokin
effici
produc
leukocyt
macrophag
dendrit
cell
promin
subset
latter
plasmacytoid
dendrit
cell
pdc
produc
macrophag
per
cell
basi
fitzgeraldbocarsli
fitzgeraldbocarsli
et
al
notabl
pdc
recogn
endocytos
viral
molecul
without
infect
via
tolllik
receptor
thu
due
prodigi
abil
produc
pdc
gener
system
wave
type
ifn
product
takeuchi
akira
sinc
pdc
mainli
found
secondari
lymphoid
tissu
blood
propos
pdc
vital
role
system
viral
infect
viru
tropism
secondari
lymphoid
organ
swiecki
colonna
macrophag
primarili
alveolar
macrophag
main
host
cell
prrsv
replic
within
day
respiratori
inocul
prrsv
infect
becom
system
result
viremia
persist
day
longer
period
prrsv
detect
secondari
lymphoid
tissu
month
thu
base
distribut
prrsv
bodi
known
trigger
signal
type
ifn
respons
two
type
cell
could
potenti
mediat
type
ifn
respons
prrsv
infect
macrophag
pdc
semin
studi
albina
et
al
indic
respons
swine
genotyp
prrsv
meager
could
even
activ
suppress
albina
et
al
sinc
signific
amount
research
focus
possibl
mechan
molecular
level
prrsv
might
inhibit
respons
sinc
topic
recent
review
extens
other
sun
et
al
review
mainli
focu
known
respons
swine
prrsv
either
vivo
porcin
cell
vitro
regard
seem
clear
unlik
swine
respiratori
virus
capabl
stimul
signific
product
porcin
respiratori
coronaviru
prcv
swine
influenza
viru
siv
prrsv
elicit
moder
neglig
respons
respiratori
tract
product
lung
pig
acut
infect
prrsv
either
almost
undetect
lower
induc
prcv
buddaert
et
al
jung
et
al
van
reeth
et
al
evid
indic
engag
virussens
pattern
recognit
receptor
prr
lung
cell
prrsvinfect
pig
report
increas
transcript
sever
viral
sens
tlr
liu
et
al
xiao
et
al
b
howev
observ
confirm
ex
vivo
experi
use
precisioncut
lung
slice
expos
prrsv
dobrescu
et
al
rigi
transcript
infect
prrsv
found
increas
level
express
strong
induc
siv
dobrescu
et
al
transcript
type
ifn
gene
monocytederiv
dendrit
cell
describ
genini
et
al
love
et
al
protein
analysi
alway
perform
addit
studi
use
quantit
realtim
pcr
elisa
analysi
shown
even
though
transcript
type
ifn
gene
occur
actual
secret
correspond
cytokin
fail
occur
dobrescu
et
al
miller
et
al
zhang
et
al
observ
led
suggest
product
type
ifn
might
regul
posttranscript
level
poor
respons
detect
lung
prrsvinfect
pig
consist
report
poor
respons
porcin
prrsv
infect
vitro
albina
et
al
dobrescu
et
al
lee
et
al
limit
type
ifn
respons
could
due
abil
viru
activ
block
respons
rapid
destruct
infect
known
occur
lung
prrsvinfect
pig
weesendorp
et
al
howev
underli
mechan
unclear
respons
porcin
pdc
prrsv
compar
virus
abl
stimul
strong
respons
cell
type
character
moder
baumann
et
al
neglig
calzadanova
et
al
although
modest
respons
porcin
pdc
prrsv
reportedli
occur
pathway
baumann
et
al
prrsv
shown
capac
strongli
inhibit
respons
pdc
porcin
virus
transmiss
gastroenter
viru
tgev
moder
inhibit
cytokin
respons
synthet
immunestimulatori
dna
baumann
et
al
calzadanova
et
al
contrast
tgev
stimul
activ
differenti
porcin
pdc
upregul
express
acquisit
dendrit
celltyp
morpholog
concomit
increas
express
exposur
pdc
prrsv
induc
activ
pathway
calzadanova
et
al
import
lack
pdc
activ
prrsv
resid
fact
pdc
appear
play
role
promot
cytotox
cell
respons
requir
help
costimul
swiecki
colonna
sinc
pdc
permiss
prrsv
live
prrsv
requir
suppress
function
inhibitori
effect
prrsv
pdc
abil
produc
unlik
due
kill
pdc
prrsv
rather
appear
prrsv
alter
pdc
function
neg
signal
deliv
cell
surfac
calzadanova
et
al
neg
signal
could
mediat
via
engag
cell
surfac
receptor
pdc
known
neg
regul
type
ifn
secret
swiecki
colonna
product
pdc
autocrin
effect
promot
function
phenotyp
activ
event
necessari
optim
express
costimulatori
molecul
subsequ
abil
pdc
induc
cell
differenti
sc
cella
et
al
fitzgeraldbocarsli
honda
et
al
kadowaki
et
al
montoya
et
al
point
cell
express
costimulatori
molecul
promot
differenti
cell
secret
cell
cella
et
al
fitzgeraldbocarsli
honda
et
al
kadowaki
et
al
cytotox
lymphocyt
swiecki
colonna
thu
becom
increasingli
evid
link
innat
adapt
immun
viral
infect
occur
interact
dendrit
cell
type
interferon
montoya
et
al
tough
dendrit
cell
control
polar
tcell
function
kapsenberg
accordingli
appar
lack
adequ
respons
swine
upon
exposur
prrsv
like
contribut
significantli
inadequ
develop
specif
cellmedi
immun
respons
meier
et
al
usual
virusinfect
cell
secret
type
ifn
releas
cytokin
interact
subset
cell
promot
convers
virusspecif
secret
cell
biron
cella
et
al
cousen
et
al
kadowaki
et
al
levi
et
al
contrast
describ
respons
swine
upon
exposur
prrsv
meager
best
lack
effici
stimul
product
host
cell
pathogen
exposur
would
expect
signific
impact
natur
host
adapt
immun
respons
sinc
upregul
gene
express
thu
control
domin
pathway
promot
develop
adapt
immun
name
cellmedi
respons
peak
antivir
immun
defens
cousen
et
al
levi
et
al
experiment
condit
presenc
time
prrsv
infect
vaccin
found
significantli
alter
innat
adapt
immun
respons
brockmeier
et
al
royae
et
al
given
promin
role
alter
prrsvspecif
immun
respons
seem
like
field
condit
individu
variabl
presenc
spontan
produc
blood
tissu
pig
may
respons
signific
level
individu
variat
observ
kinet
intens
cellmedi
immun
respons
follow
vaccin
modifi
live
viru
royae
et
al
support
observ
statist
signific
p
correl
r
frequenc
vaccin
swine
royae
et
al
regardless
clear
data
indic
signific
differ
viral
clearanc
adapt
immun
respons
present
time
prrsv
infect
brockmeier
et
al
brockmeier
et
al
given
influenc
innat
immun
respons
subsequ
develop
adapt
immun
respons
much
effort
direct
compens
appar
inadequ
innat
cytokin
stimul
elicit
follow
prrsv
infect
novel
adjuv
use
immun
attempt
overcom
deficit
innat
stimul
includ
administr
combin
live
kill
prrsv
vaccin
result
increas
lymphoprolif
respons
vaccin
viru
wee
et
al
well
enhanc
respons
modifiedl
prrsv
vaccin
foss
et
al
similarli
inject
provid
exogen
form
express
cdna
replicationdefect
adenoviru
vector
found
exert
enhanc
effect
induct
antigenspecif
respons
prrsv
brockmeier
et
al
meier
et
al
remark
signific
alter
develop
humor
immun
respons
observ
either
treatment
intervent
initi
prrsv
immun
alter
usual
rapid
onset
antiprrsv
antibodi
product
delay
appear
serum
viru
neutral
antibodi
brockmeier
et
al
labarqu
et
al
meier
et
al
ostrowski
et
al
prrsv
engin
express
ifn
shown
limit
replic
coinfect
prrsv
effect
prrsvspecif
adapt
immun
vivo
elucid
sang
et
al
sang
et
al
howev
recent
studi
util
strain
prrsv
induc
strong
type
ifn
respons
abl
show
increas
viru
neutral
antibodi
time
develop
level
wang
et
al
thu
mechan
andor
pathway
involv
type
ifn
induct
may
effect
subsequ
immun
respons
observ
deliveri
cdna
pronounc
sustain
effect
intens
cellmedi
immun
respons
meier
et
al
likewis
introduct
type
interferon
agonist
poli
c
synthet
doublestrand
rna
vaccin
temporarili
amplifi
number
prrsvspecif
sc
howev
polyi
c
effici
encod
plasmid
deliv
vaccin
enhanc
respons
prrsv
observ
inclus
either
immun
increas
intens
respons
prrsv
valid
propos
role
two
innat
cytokin
direct
vivo
differenti
swine
cell
help
explain
poor
virusspecif
respons
develop
result
exposur
pig
prrsv
meier
et
al
xiao
et
al
coadministr
adjuv
modifiedl
prrsv
also
shown
enhanc
earli
cellular
immun
though
connect
innat
immun
activ
made
mair
et
al
plausibl
role
mediat
protect
immun
prrsv
support
abil
cytokin
inhibit
prrsv
replic
simian
cell
line
well
porcin
connect
protect
immun
prrsv
vivo
impli
correl
frequenc
virusspecif
secret
cell
clinic
outcom
upon
prrsv
infect
charerntantanakul
et
al
low
et
al
martelli
et
al
major
focu
assess
improv
vaccin
efficaci
stimul
strong
cell
mediat
respons
upon
immun
although
studi
need
demonstr
direct
caus
effect
protect
immun
least
measur
cellmedi
immun
measur
frequenc
secret
cell
serv
gaug
stimul
immun
respons
use
addit
technolog
measur
virusspecif
ctl
might
enabl
establish
stronger
correl
protect
immun
cmi
thu
facilit
develop
highli
efficaci
biolog
ultim
howev
best
measur
protect
immun
trigger
effect
vaccin
pig
remain
healthi
immun
abl
minim
replic
prrsv
challeng
infect
model
central
strategi
control
elimin
anim
infecti
diseas
vaccin
induc
without
advers
effect
rapid
steril
immun
prevent
infect
upon
exposur
case
prrsv
goal
achiev
reason
yet
deduc
purpos
review
highlight
known
prrsv
immun
focu
key
area
may
help
enhanc
vaccin
strategi
achiev
rapid
complet
steril
immun
prrsv
move
forward
prrsv
immunolog
research
identifi
two
direct
research
area
achiev
goal
first
research
direct
identifi
mechan
involv
prevent
pig
develop
rapid
steril
immun
follow
infect
ie
delay
develop
convalesc
immun
soon
infect
requir
basic
yet
mechanist
understand
prrsv
pathogenesi
identif
prrsv
protein
alter
induct
host
innat
immun
respons
research
area
particular
full
content
disagr
conflict
result
specif
mani
conflict
report
abil
prrsv
infect
alter
immun
respons
antigen
infecti
agent
deliv
simultan
prrsv
infect
nevertheless
wide
accept
prrsv
predispos
agent
develop
porcin
respiratori
diseas
complex
prdc
prrsv
infect
leav
pig
herd
suscept
varieti
secondari
infect
associ
prrsv
secondari
infect
highlight
challeng
determin
prrsv
suppress
immun
resist
virul
pathogen
andor
weaken
physiolog
control
mechan
endogen
microorgan
caus
diseas
presenc
absenc
prrsv
known
viru
alter
basic
host
immun
seem
develop
modifiedl
vaccin
deriv
virul
field
virus
would
unlik
yield
markedli
better
protect
current
achiev
mechan
attenu
current
avail
commerci
modifiedl
vaccin
known
induct
immun
rel
slow
similar
natur
infect
thu
research
focus
mechan
prrsv
affect
host
immun
system
includ
innat
respons
cell
develop
antigen
present
induct
prrsvspecif
lymphocyt
need
explain
inabl
pig
develop
rapid
steril
immun
follow
infect
secondli
research
direct
identif
protect
immunogen
epitop
elucid
immun
mechan
antigenspecif
protect
essenti
ration
develop
vaccin
provid
rapid
protect
prrsv
prrsv
immunogen
epitop
protect
mechan
unquestion
exist
sinc
steril
immun
natur
infect
achiev
given
suffici
time
mechanist
understand
immun
primari
infect
might
gain
dissect
immun
adult
anim
achiev
steril
protect
present
major
research
conduct
grow
swine
complet
elimin
viral
infect
thu
time
adapt
immun
evalu
critic
clear
determin
convalesc
protect
immun
antigen
deliveri
system
deliv
key
immunogen
epitop
might
avenu
basic
research
clearli
identifi
protect
epitop
prrsv
vaccin
achiev
rapid
protect
reduc
suscept
secondari
infect
overal
deliveri
protect
epitop
immunogen
outsid
context
prrsv
infect
ie
absenc
viral
pathogenesi
may
help
reveal
protect
mechan
easili
achiev
goal
develop
prrsv
vaccin
rapidli
induc
protect
immun
two
primari
research
area
outlin
would
ideal
pursu
simultan
use
natur
viral
infect
model
antigen
deliveri
system
prrsv
immun
research
must
move
beyond
observ
studi
identif
mechan
immun
function
significantli
advanc
beyond
current
stage
knowledg
requir
full
understand
modul
effect
prrsv
innat
immun
respons
vivo
addit
method
mechanist
evalu
immun
cell
function
cultur
immort
porcin
antigenspecif
b
lymphocyt
need
abil
evalu
immun
cell
function
requir
sustain
commit
invest
independ
particular
pathogen
invest
extrem
benefici
understand
prrsv
immun
well
immun
swine
infecti
diseas
collect
approach
move
us
forward
challeng
prr
also
emerg
diseas
swine
